TBPH

TBPH

USD

Theravance Biopharma Inc. Ordinary Shares

$14.750-0.110 (-0.740%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$14.860

High

$15.001

Low

$14.420

Volume

0.49M

Company Fundamentals

Market Cap

742.8M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.42M

Exchange

NGM

Currency

USD

52-Week Range

Low $7.9Current $14.750High $15.335

Related News

PR Newswire

Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System

Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it will be participating at the 36th International Symposium on the Autonomic Nervous...

View more
Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System
PR Newswire

Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025

Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its third quarter 2025 financial results and provide a business update after market close on...

View more
Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025
PR Newswire

Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH), today announced that it will be presenting two rapid-fire...

View more
Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting